Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bosch Introduces CIP System for Use with Human Vaccines
Wednesday, October 01, 2014
Closed system for high operator protection.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

Almac Doubles Global 2-8°C Cold Room Capacity
Tuesday, September 30, 2014
Dedicated temperature and humidity controlled labelling suites go live in USA and Europe as business from biosimilars and biologics clinical studies expands.

New CombiCult® Technology Massively Accelerates Development of Stem Cell Cures
Friday, September 26, 2014
CombiCult® technology enables a single scientist to carry out 10,000 stem cell biology experiments in parallel.

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends
Wednesday, September 24, 2014
Collagenase/neutral protease blends from bacterial source minimize contamination threat.

Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Tuesday, September 23, 2014
Company receives award as a national winner for its VAX-ID device.

RAININ's New LR Low Retention Pipette Tips
Tuesday, September 23, 2014
New tips will improve users pipetting accuracy.

Malvern Explores Rheology for Protein Formulation at 2nd Protein-Protein Interaction Conference
Thursday, September 18, 2014
Malvern Instruments will contribute a scientific poster at the 2014 Protein-Protein Interaction Conference, October 23-24, Boston, MA, USA.

New Application Note for TAP’s ambr15 Micro Bioreactors
Friday, September 12, 2014
Provides tips on how to maximize data collection with minimum sample volume and smart sampling regimes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 468
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv